Document:

Exhibit 10.9

 

VOTING AGREEMENT

 

by and among, on the one hand,

 

GAMEPLAN, INC., a Nevada corporation

 

and

 

KEY HOLDERS AS LISTED HEREIN

 

and

 

KGPLA HOLDINGS LLC, AS THE LEAD INVESTOR, AND
THE OTHER INVESTORS LISTED HEREIN

 

dated as of

 

January ___, 2020

 

 

 

 

    	 	1	 

     

    

 

TABLE OF CONTENTS

 

	1.	Voting Provisions Regarding the Board	1
	 	 	 
	 	1.1	Size of the Board	1
	 	1.2	Board Composition	1
	 	1.3	Failure to Designate a Board Member	2
	 	1.4	Removal of Board Members	2
	 	1.5	No Liability for Election of Recommended Directors	3
	 	1.6	Vote to Increase Authorized Common Stock	3
	 	 	 	 
	2.	Remedies	3
	 	 	 
	 	2.1	Covenants of the Company	3
	 	2.2	Specific Enforcement	3
	 	2.3	Remedies Cumulative	3
	 	 	 	 
	3.	“Bad Actor”	3
	 	 	 
	 	3.1	Definitions	3
	 	3.2 	Representations	4
	 	3.3 	Covenants	4
	 	 	 	 
	4.	Term	4
	 	 	 
	5.	Miscellaneous	4
	 	 	 
	 	5.1	Additional Parties	4
	 	5.2 	Transfers	 
	 	5.3	Successors and Assigns	5
	 	5.4	Governing Law	5
	 	5.5 	Counterparts	5
	 	5.6	Titles and Subtitles	5
	 	5.7	Notices	5
	 	5.8	Consent Required to Amend, Modify, Terminate or Waive	6
	 	5.9	Delays or Omissions	7
	 	5.10 	Severability	7
	 	5.11 	Entire Agreement	7
	 	5.12 	Share Certificate Legend	7
	 	5.13 	Stock Splits, Stock Dividends, Etc	7
	 	5.14 	Manner of Voting	7
	 	5.15 	Further Assurances	7
	 	5.16 	Dispute Resolution	8
	 	5.17 	Aggregation of Stock	8
	 	5.18 	Spousal Consent	8

 

 

 

    	 	2	 

     

    

VOTING AGREEMENT

 

THIS VOTING AGREEMENT (this
“Agreement”), is made as of the January ___, 2020, by and among GamePlan, Inc., a Nevada corporation (the “Company”),
the Lead Investor and each of the investors listed on Schedule A, each of which is referred to in this Agreement as an “Investor”,
and each of the stockholders listed on Schedule B, each of whom is referred to herein as a “Key Holder”, and
any Additional Investor (as defined in that certain Securities Purchase Agreement dated of even date herewith (the “Purchase
Agreement”)) that becomes a party to this Agreement in accordance with its terms. Capitalized terms used but not otherwise defined
herein shall have the meanings set forth in the Purchase Agreement. For purposes of this Agreement, Lead Investor, any Investor that is
made a party, Key Holders and the holders of common stock of the Company shall be referred to individually as a “Stockholder”
and, collectively, as the “Stockholders”.

 

RECITALS

 

A.             
Concurrently with the execution of this Agreement, the Company and the Investors are entering into a Securities Purchase Agreement (the
“Purchase Agreement”) providing for the sale of Convertible Debentures, and in connection with that agreement the parties
desire to provide the Investors with the right, among other rights, to designate the election of certain members of the board of directors
of the Company (the “Board”) in accordance with the terms of this Agreement.

 

B.              
The Amended and Restated Articles of Incorporation of the Company (the “Amended Articles”) provides that the Lead Investor
under the Purchase Agreement, exclusively and as a separate class on an as-converted basis, shall be entitled to elect three (3) out of
five (5) directors of the Company (the “Lead Investor Directors”) and the Key Holders of record of the shares of common
stock, $0.001 par value per share, of the Company (“Common Stock”), exclusively and as a separate class, shall be entitled
to elect two (2) of five (5) directors of the Company for so long as such Key Holders maintain a certain amount of such shares pursuant
to this Agreement.

 

C.              
The parties also desire to enter into this Agreement to set forth their agreements and understandings with respect to how shares of the
capital stock of the Company and Convertible Debentures voted on an as-converted basis held by them will be voted on, or tendered in connection
with, an acquisition of the Company, or an increase in the number of shares of Common Stock required to provide for the conversion of
the Convertible Debentures or any other convertible securities of the Company.

 

NOW, THEREFORE, the parties agree as follows:

 

1.       Voting
Provisions Regarding the Board.

 

1.1       Size
of the Board. Each Stockholder agrees to vote, or cause to be voted, all Shares (as defined below) owned by such Stockholder, or over
which such Stockholder has voting control, from time to time and at all times, in whatever manner as shall be necessary to ensure that
the size of the Board shall be set and remain at five (5) directors and may be increased only with the written consent of the Lead Investor
(voting as a single separate class and on an as-converted to Common Stock basis). For purposes of this Agreement, the term “Shares”
shall mean and include any securities of the Company that the holders of which are entitled to vote for members of the Board, including
without limitation, all shares of Common Stock and the Convertible Debentures on an as-converted basis in Common Stock, by whatever name
called, now owned or subsequently acquired by a Stockholder, however acquired, whether through stock splits, stock dividends, reclassifications,
recapitalizations, similar events or otherwise.

 

1.2       Board
Composition. Each Stockholder agrees to vote, or cause to be voted, all Shares owned by such Stockholder, or over which such Stockholder
has voting control, from time to time and at all times, in whatever manner as shall be necessary to ensure that at each annual or special
meeting of stockholders at which an election of directors is held or pursuant to any written consent of the stockholders, subject to Section
4, the following persons shall be elected to the Board:

 

 

    	 	3	 

     

    

(a)             
Three (3) persons designated from time to time by the Lead Investor, for so long as such Stockholder and its Affiliates (as defined below)
continue to own any “Lead Investor Common Stock” as defined in the Amended Articles (i.e., a total of 1,521,141,192
shares of common stock), which number is subject to appropriate adjustment for any stock splits, stock dividends, combinations, recapitalizations
and the like), which individuals shall be named as of the Closing pursuant to the Purchase Agreement, and, for clarification any shares
of Lead Investor Common Stock resold by the Lead Investor to any other Person that is not an Affiliate of Lead Investor shall cease to
become Lead Investor Common Stock for purposes hereof;

 

(b)            
Subject to Section 1.2(c), for so long as the Key Holders who are then providing services to the Company as officers, employees or consultants
hold at least an amount of shares designated as “Key Holder Common Stock” as defined in the Amended Articles (i.e.,
a total of 868,960,471 shares of common stock) representing ten percent (10%) of the Company’s total issued and outstanding shares
(subject to appropriate adjustment for any stock splits, stock dividends, combinations, recapitalizations and the like), two (2) individuals
designated from time to time by the holders of a majority of the shares of Common Stock held by the Key Holders, which individuals shall
be named as of the Closing pursuant to the Purchase Agreement, and, for clarification any shares of Key Holder Common Stock resold by
a Key Holder to any other Person that is not an Affiliate of such Key Holder shall cease to become Key Holder Common Stock for purposes
hereof;

 

(c)             
One (1) of the Key Holders’ individual designees to the Board pursuant to this Section 1.2(c), shall be the then-serving Chief Executive
Officer of the Company (The “CEO Director”, which, as of the date hereof, is Eric Gravengaard for so long as he serves
as Chief Executive Officer of the Company), provided that, if for any reason the then-serving Chief Executive Officer shall cease to serve
as the Chief Executive Officer of the Company, each of the Key Holders shall promptly vote their respective Shares: (i) to remove such
former Chief Executive Officer of the Company from the Board if such person has not resigned as a member of the Board; and (ii) to elect
such person’s replacement as Chief Executive Officer of the Company as the new CEO Director; and

 

To the extent that any of clauses (a) through
(c) above shall not be applicable, any member of the Board who would otherwise have been designated in accordance with the terms thereof
shall instead be voted upon by all the stockholders of the Company entitled to vote thereon in accordance with, and pursuant to, the Amended
Articles.

 

For purposes of this Agreement,
an individual, firm, corporation, partnership, association, limited liability company, trust or any other entity (collectively, a “Person”)
shall be deemed an “Affiliate” of another Person who, directly or indirectly, controls, is controlled by or is under
common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of
such Person, or any venture capital fund or registered investment company now or hereafter existing that is controlled by one or more
general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.

 

1.3       Failure
to Designate a Board Member. In the absence of any designation from the Persons or groups with the right to designate a director as
specified above, the director previously designated by them and then serving shall be reelected if still eligible and willing to serve
as provided herein and otherwise, such Board seat shall remain vacant.

 

1.4       Removal
of Board Members. Each Stockholder also agrees to vote, or cause to be voted, all Shares owned by such Stockholder, or over which
such Stockholder has voting control, from time to time and at all times, in whatever manner as shall be necessary to ensure that:

 

(a)       no
director elected pursuant to Sections 1.2 or Section 1.3 of this Agreement may be removed from office other than for cause unless (i)
such removal is directed or approved by the affirmative vote of the Person(s) entitled under Section 1.2 to designate that director; or
(ii) the Person(s) originally entitled to designate or approve such director or occupy such Board seat pursuant to Section 1.2 is no longer
so entitled to designate or approve such director or occupy such Board seat;

 

    	 	4	 

     

    

 

 

(b)            
any vacancies created by the resignation, removal or death of a director elected pursuant to Sections 1.2 or Section 1.3 shall be filled
pursuant to the provisions of this Section 1; and

 

(c)             
upon the request of any party entitled to designate a director as provided in Section 1.2(a) or Section 1.2(b) to remove such director,
such director shall be removed.

 

All Stockholders agree to execute any written
consents required to perform the obligations of this Section 1, and the Company agrees at the request of any Person or group entitled
to designate directors to call a special meeting of stockholders for the purpose of electing directors.

 

1.5       No
Liability for Election of Recommended Directors. No Stockholder, nor any Affiliate of any Stockholder, shall have any liability as
a result of designating a person for election as a director for any act or omission by such designated person in his or her capacity as
a director of the Company, nor shall any Stockholder have any liability as a result of voting for any such designee in accordance with
the provisions of this Agreement.

 

1.6       Vote
to Increase Authorized Common Stock. Each Stockholder agrees to vote or cause to be voted all Shares owned by such Stockholder, or
over which such Stockholder has voting control, from time to time and at all times, in whatever manner as shall be necessary to increase
the number of authorized shares of Common Stock from time to time to ensure that there will be sufficient shares of Common Stock available
for conversion of all Convertible Debentures outstanding at any given time.

 

2.             
Remedies.

 

2.1       Covenants
of the Company. The Company agrees to use its best efforts, within the requirements of applicable law, to ensure that the rights granted
under this Agreement are effective and that the parties enjoy the benefits of this Agreement. Such actions include, without limitation,
the use of the Company’s best efforts to cause the nomination and election of the directors as provided in this Agreement.

 

2.2       Specific
Enforcement. Each party acknowledges and agrees that each party hereto will be irreparably damaged in the event any of the provisions
of this Agreement are not performed by the parties in accordance with their specific terms or are otherwise breached. Accordingly, it
is agreed that each of the Company and the Stockholders shall be entitled to an injunction to prevent breaches of this Agreement, and
to specific enforcement of this Agreement and its terms and provisions in any action instituted in any court of the United States or any
state having subject matter jurisdiction.

 

2.3       Remedies
Cumulative. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

 

3.             
“Bad Actor” Matters.

 

3.1       Definitions.
For purposes of this Agreement:

 

(a)             
“Company Covered Person ”means, with respect to the Company as an “issuer” for purposes of Rule 506 promulgated
under the Securities Act, any Person listed in the first paragraph of Rule 506(d)(1).

 

(b)            
“Disqualified Designee ”means any director designee to whom any Disqualification Event is applicable, except for a
Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable.

 

(c)             
“Disqualification Event ”means a “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii)
promulgated under the Securities Act.

 

 

    	 	5	 

     

    

 

 

(d)            
“Rule 506(d) Related Party ”means, with respect to any Person, any other Person that is a beneficial owner of such
first Person’s securities for purposes of Rule 506(d) under the Securities Act.

 

(e)             
“Securities Act ”means the Securities Act of 1933, as amended.

 

3.2       Representations.

 

(a)             
Each Person with the right to designate or participate in the designation of a director pursuant to this Agreement hereby represents that
(i) such Person has exercised reasonable care to determine whether any Disqualification Event is applicable to such Person, any director
designee designated by such Person pursuant to Purchase Agreement or any of such Person’s Rule 506(d) Related Parties, except, if
applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable and (ii) no Disqualification
Event is applicable to such Person, any Board member designated by such Person pursuant to the Purchase Agreement or any of such Person’s
Rule 506(d) Related Parties, except, if applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is
applicable. Notwithstanding anything to the contrary in this Agreement, each Investor makes no representation regarding any Person that
may be deemed to be a beneficial owner of the Company’s voting equity securities held by such Investor solely by virtue of that
Person being or becoming a party to (x) this Agreement, as may be subsequently amended, or (y) any other contract or written agreement
to which the Company and such Investor are parties regarding (1) the voting power, which includes the power to vote or to direct the voting
of, such security; and/or (2) the investment power, which includes the power to dispose, or to direct the disposition of, such security.

 

(b)            
The Company hereby represents and warrants to the Investors that no Disqualification Event is applicable to the Company or, to the Company’s
knowledge, any Company Covered Person, except for a Disqualification Event as to which Rule 506(d)(2)(ii–iv) or (d)(3) is applicable.

 

3.3       Covenants.
Each Person with the right to designate or participate in the designation of a director pursuant to this Agreement covenants and agrees
(i) not to designate or participate in the designation of any director designee who, to such Person’s knowledge, is a Disqualified
Designee, (ii) to exercise reasonable care to determine whether any director designee designated by such person is a Disqualified Designee,
(iii) that in the event such Person becomes aware that any individual previously designated by any such Person is or has become a Disqualified
Designee, such Person shall as promptly as practicable take such actions as are necessary to remove such Disqualified Designee from the
Board and designate a replacement designee who is not a Disqualified Designee, and (iv) to notify the Company promptly in writing in the
event a Disqualification Event becomes applicable to such Person or any of its Rule 506(d) Related Parties, or, to such Person’s
knowledge, to such Person’s initial designee named in Section 1, except, if applicable, for a Disqualification Event as to which
Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable.

 

4.             
Term. This Agreement shall be effective as of the date hereof and shall continue in effect until and shall terminate upon the
earliest to occur of: (a) the consummation of the Company’s first underwritten public offering of its Common Stock on the NYSE or
NASDAQ (other than a registration statement relating either to the sale of securities to employees of the Company pursuant to its stock
option, stock purchase or similar plan or an SEC Rule 145 transaction or registration on other than a first tier U.S. or Canadian exchange);
and (b) termination of this Agreement in accordance with Section 5.8.

 

5.             
Miscellaneous.

 

5.1       Additional
Parties.

 

(a)       Notwithstanding
anything to the contrary contained herein, if the Company issues additional Convertible Debentures after the date hereof, as a condition
to the issuance of such shares the Company shall require that any purchaser of such shares become a party to this Agreement by executing
and delivering (i) the Adoption Agreement attached to this Agreement as Exhibit A, or (ii) a counterpart signature page hereto
agreeing to be bound by and subject to the terms of this Agreement as an Investor and Stockholder hereunder. In either event, each such
person shall thereafter be deemed an Investor and Stockholder for all purposes under this Agreement.

 

 

 

 

    	 	6	 

     

    

 

(b)       In
the event that after the date of this Agreement, the Company enters into an agreement with any Person to issue shares of capital stock
to such Person, following which such Person shall hold Shares constituting one percent (1%) or more of the then outstanding capital stock
of the Company (treating for this purpose all shares of Common Stock issuable upon exercise of or conversion of outstanding options, warrants
or convertible securities, as if exercised and/or converted or exchanged), then, the Company shall cause such Person, as a condition precedent
to entering into such agreement, to become a party to this Agreement by executing an Adoption Agreement in the form attached hereto as
Exhibit A, agreeing to be bound by and subject to the terms of this Agreement as a Stockholder and thereafter such person shall
be deemed a Stockholder for all purposes under this Agreement.

 

5.2       Transfers.
Each transferee or assignee of any Shares subject to this Agreement shall continue to be subject to the terms hereof, and, as a condition
precedent to the Company’s recognition of such transfer, each transferee or assignee shall agree in writing to be subject to each
of the terms of this Agreement by executing and delivering an Adoption Agreement substantially in the form attached hereto as Exhibit
A. Upon the execution and delivery of an Adoption Agreement by any transferee, such transferee shall be deemed to be a party hereto
as if such transferee were the transferor and such transferee’s signature appeared on the signature pages of this Agreement and
shall be deemed to be an Investor and Stockholder, or Key Holder and Stockholder, as applicable. The Company shall not permit the transfer
of the Shares subject to this Agreement on its books or issue a new certificate representing any such Shares unless and until such transferee
shall have complied with the terms of this Section 5.2. Each certificate instrument, or book entry representing the Shares subject to
this Agreement if issued on or after the date of this Agreement shall be notated by the Company with the legend set forth in Section 5.12.

 

5.3       Successors
and Assigns. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors
and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties
hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement,
except as expressly provided in this Agreement.

 

5.4       Governing
Law. This Agreement shall be governed by the internal law of the State of Delaware, without regard to conflict of law principles that
would result in the application of any law other than the law of the State of Delaware.

 

5.5       Counterparts.
This Agreement may be executed in two (2) or more counterparts, each of  which shall be deemed an original, but all of which together
shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic
signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other
transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective
for all purposes.

 

5.6       Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing
or interpreting this Agreement.

 

5.7       Notices.

 

(a)       All
notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon
the earlier of actual receipt or (a) personal delivery to the party to be notified, (b) when sent, if sent by electronic mail or facsimile
during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next business
day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1)
business day after the business day of deposit with a nationally recognized overnight courier, freight prepaid,

 

 

 

    	 	7	 

     

    

 

 

specifying next business day delivery, with
written verification of receipt. All communications shall be sent to the respective parties at their address as set forth on Schedule
A or Schedule B, or to such email address, facsimile number or address as subsequently modified by written notice given in
accordance with this Section 5.7.

 

(b)       Each
Investor and Key Holder consents to the delivery of any stockholder notice pursuant to, insofar as it is consistent with Nevada law applicable
to stockholders of a Nevada corporation (and if not, then in accordance with the Nevada Business Corporation Act), the Delaware General
Corporation Law (the “DGCL”), as amended or superseded from time to time, by electronic transmission pursuant to Section 232
of the DGCL (or any successor thereto) at the electronic mail address or the facsimile number set forth below such Investor’s or
Key Holder’s name on the Schedules hereto, as updated from time to time by notice to the Company, or as on the books of the Company.
To the extent that any notice given by means of electronic transmission is returned or undeliverable for any reason, the foregoing consent
shall be deemed to have been revoked until a new or corrected electronic mail address has been provided, and such attempted Electronic
Notice shall be ineffective and deemed to not have been given. Each Investor and Key Holder agrees to promptly notify the Company of any
change in its electronic mail address, and that failure to do so shall not affect the foregoing.

 

5.8       Consent
Required to Amend, Modify, Terminate or Waive. This Agreement may be amended, modified or terminated (other than pursuant to Section
3.1) and the observance of any term hereof may be waived (either generally or in a particular instance and either retroactively or prospectively)
only by a written instrument executed by (a) the Company; (b) the Key Holders of the Shares then held by the Key Holders who are then
providing services to the Company as officers, employees or consultants; and (c) the Lead Investor. Notwithstanding the foregoing:

 

(a)             
this Agreement may not be amended, modified or terminated and the observance of any term of this Agreement may not be waived with respect
to any Investor or Key Holder without the written consent of such Investor or Key Holder unless such amendment, modification, termination
or waiver applies to all Investors or Key Holders, as the case may be, in the same fashion;

 

(b)            
the provisions of Section 1.2(a) and this Section 5.8(b) may not be amended, modified, terminated or waived without the written consent
of the Lead Investor;

 

(c)             
the provisions of Section 1.2(b) and this Section 5.8(c) may not be amended, modified, terminated or waived without the written consent
of the Key Holders who are at such time providing services to the Company as an officer, employee or consultant;

 

(d)            
the consent of the Key Holders shall not be required for any amendment, modification, termination or waiver if such amendment, modification,
termination, or waiver either (A) is not directly applicable to the rights of the Key Holders hereunder; or (B) does not adversely affect
the rights of the Key Holders in a manner that is different than the effect on the rights of the other parties hereto;

 

(e)             
Schedule A may be amended by the Company from time to time in accordance with Section 1.3 of the Purchase Agreement to add
information regarding additional Investors (as defined in the Purchase Agreement) without the consent of the other parties hereto; and

 

(f)             
any provision hereof may be waived by the waiving party on such party’s own behalf, without the consent of any other party.

 

The Company shall give prompt written notice
of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto. Any amendment,
modification, termination, or waiver effected in accordance with this Section 5.8 shall be binding on each party and all of such party’s
successors and permitted assigns, whether or not any such party, successor or assignee entered into or approved such amendment, modification,
termination or waiver. For purposes of this Section 5.8, the requirement of a written instrument may be satisfied in the form of an action
by written consent of the Stockholders circulated by the Company and executed

 

 

    	 	8	 

     

    

 

 

by the Stockholder parties specified,
whether or not such action by written consent makes explicit reference to the terms of this Agreement.

 

5.9       Delays
or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach
or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting
party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach
or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default
previously or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach
or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in
writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or
by law or otherwise afforded to any party, shall be cumulative and not alternative.

 

5.10       
Severability. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of
any other provision.

 

5.11       Entire
Agreement. This Agreement (including its preamble, recitals, and any Schedules and Exhibits hereto), and the Purchase Agreement, and
the Amended Articles, and the other Transaction Agreements (as defined in the Purchase Agreement) constitute the full and entire understanding
and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject
matter hereof existing between the parties is expressly canceled.

 

5.12       Share
Certificate Legend. Each certificate, instrument, or book entry representing any Shares issued after the date hereof shall be notated
by the Company with a legend reading substantially as follows:

 

“THE SHARES REPRESENTED HEREBY ARE SUBJECT
TO A VOTING AGREEMENT, AS MAY BE AMENDED FROM TIME TO TIME, (A COPY OF WHICH MAY BE OBTAINED UPON WRITTEN REQUEST FROM THE COMPANY), AND
BY ACCEPTING ANY INTEREST IN SUCH SHARES THE PERSON ACCEPTING SUCH INTEREST SHALL BE DEEMED TO AGREE TO AND SHALL BECOME BOUND BY ALL
THE PROVISIONS OF THAT VOTING AGREEMENT, INCLUDING CERTAIN RESTRICTIONS ON TRANSFER AND OWNERSHIP SET FORTH THEREIN.”

 

The Company, by its execution of this
Agreement, agrees that it will cause the certificates instruments, or book entry evidencing the Shares issued after the date hereof to
be notated with the legend required by this Section 5.12 of this Agreement, and it shall supply, free of charge, a copy of this Agreement
to any holder of such Shares upon written request from such holder to the Company at its principal office. The parties to this Agreement
do hereby agree that the failure to cause the certificates, instruments, or book entry evidencing the Shares to be notated with the legend
required by this Section 5.12 herein and/or the failure of the Company to supply, free of charge, a copy of this Agreement as provided
hereunder shall not affect the validity or enforcement of this Agreement.

 

5.13       Stock
Splits, Stock Dividends, Etc. In the event of any issuance of Shares or the voting securities of the Company hereafter to any of the
Stockholders (including, without limitation, in connection with any stock split, stock dividend, recapitalization, reorganization, or
the like), such Shares shall become subject to this Agreement and shall be notated with the legend set forth in Section 5.12.

 

5.14       Manner
of Voting. The voting of Shares pursuant to this Agreement may be effectuated in person, by proxy, by written consent or in any other
manner permitted by applicable law. For the avoidance of doubt, voting of the Shares pursuant to the Agreement need not make explicit
reference to the terms of this Agreement.

 

5.15 Further Assurances.
At any time or from time to time after the date hereof, the parties agree to cooperate with each other, and at the request of any other
party, to execute and deliver any further instruments or documents and to take all such further action as the other party may reasonably
request in order to carry out the intent of the parties hereunder.

 

    	 	9	 

     

    

 

 

5.16       Dispute
Resolution. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of Miami-Dade County,
Florida, and to the jurisdiction of the United States District Courts for the Southern District of Florida or the purpose of any suit,
action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding
arising out of or based upon this Agreement except in the state courts of Florida or the United States District Court for the Southern
District of Florida, and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action
or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt
or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the
suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court. WAIVER
OF JURY TRIAL: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT,
THE OTHER TRANSACTION DOCUMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING
OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION,
CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION
HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY
FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY
WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.

 

5.17       Aggregation
of Stock. All Shares held or acquired by a Stockholder and/or its Affiliates shall be aggregated together for the purpose of determining
the availability of any rights under this Agreement, and such Affiliated persons may apportion such rights as among themselves in any
manner they deem appropriate.

 

5.18       Spousal
Consent. If any individual Stockholder is married on the date of this Agreement, such Stockholder’s spouse shall execute and
deliver to the Company a consent of spouse in the form of 0 hereto (“Consent of Spouse”), effective on the date hereof.
Notwithstanding the execution and delivery thereof, such consent shall not be deemed to confer or convey to the spouse any rights in such
Stockholder’s Shares that do not otherwise exist by operation of law or the agreement of the parties. If any individual Stockholder
should marry or remarry subsequent to the date of this Agreement, such Stockholder shall within thirty (30) days thereafter obtain his/her
new spouse’s acknowledgement of and consent to the existence and binding effect of all restrictions contained in this Agreement
by causing such spouse to execute and deliver a Consent of Spouse acknowledging the restrictions and obligations contained in this Agreement
and agreeing and consenting to the same.

 

[Signature Page Follows]

 

 

    	 	10	 

     

    

 

 

 

 

IN WITNESS WHEREOF, the parties have executed this Voting Agreement
as of the date first written above.

 

 

	 	
    COMPANY:

     

    GAMEPLAN, INC., a Nevada corporation

     

    By:_________________

    Name: Eric Gravengaard

    Title: CEO

     

    KEY HOLDERS

     

    By:_________________

    Name: Eric Gravengaard

     

    LEAD INVESTOR:

     

    KGPLA Holdings, LLC

     

    By:_________________

    Name: Mike Komaransky

    Title: Authorized Person

 

[Signature Page to Voting Agreement]

 

    	 	11	 

     

    

 

SCHEDULE A

 

Investors

 

	Lead Investor Name	Lead Investor Address for Notice Purposes
	KGPLA Holdings, LLC, a Delaware limited liability company	
    Attn: Mike Komaransky, Authorized Person

    (mkomaransky@gmail.com), 850 New Burton Road, Suite 201, Dover, DE 19904

     

	Investor Name	Investor Address for Notice Purposes	 
	 	 	 	 	 
	 	 	 	 	 

 

 

SCHEDULE B

 

 Key Holders

 

	Key Holder Name	Key Holder Address for Notice Purposes
	Eric Gravengaard	211 W. Wacker Dr., Suite 1500a, Chicago, IL 60606, 

eric@athenabitcoin.com

 

 

 

 

 

 

    	 	12	 

     

    

EXHIBIT A

 

ADOPTION AGREEMENT

 

This Adoption Agreement (“Adoption
Agreement”) is executed on__________, 20__, by the undersigned (the “Holder”) pursuant to the terms of that
certain Voting Agreement dated as of _____ __, 20___ (the “Agreement”), by and among GamePlan, Inc., a Nevada corporation
(the “Company”) and certain of its Stockholders, as such Agreement may be amended or amended and restated hereafter. Capitalized
terms used but not defined in this Adoption Agreement shall have the respective meanings ascribed to such terms in the Agreement. By the
execution of this Adoption Agreement, the Holder agrees as follows.

 

1.1       Acknowledgement.
Holder acknowledges that Holder is acquiring certain shares of the capital stock of the Company (the “Stock”) or options,
warrants, or other rights to purchase such Stock (the “Options”), for one of the following reasons (Check the correct
box):

 

	 	☐	As a transferee of Shares from a party in such party’s capacity as an “Investor” bound by the Agreement, and after such transfer, Holder shall be considered an “Investor” and a “Stockholder” for all purposes of the Agreement.
	 	 	 
	 	☐	As a transferee of Shares from a party in such party’s capacity as a “Key Holder” bound by the Agreement, and after such transfer, Holder shall be considered a “Key Holder” and a “Stockholder” for all purposes of the Agreement.
	 	 	 
	 	☐	As a new Investor in accordance with Section 5.1(a) of the Agreement, in which case Holder will be an “Investor” and a “Stockholder” for all purposes of the Agreement.
	 	 	 
	 	☐	In accordance with Section 5.1(b) of the Agreement, as a new party who is not a new Investor, in which case Holder will be a “Stockholder” for all purposes of the Agreement.

 

1.2       Agreement.
Holder hereby (a) agrees that the Stock or the Options, and any other shares of capital stock or securities required by the Agreement
to be bound thereby, shall be bound by and subject to the terms of the Agreement and (b) adopts the Agreement with the same force and
effect as if Holder were originally a party thereto.

 

1.3       Notice.
Any notice required or permitted by the Agreement shall be given to Holder at the address or facsimile number listed below Holder’s
signature hereto.

 

 

 

	HOLDER:	 	ACCEPTED AND AGREED:
	 	 	 
	By: ________________________	 	COMPANY
	Name and Title of Signatory	 	 
	 	 	 
	 	 	 
	Address: _________________________	 	By:
	 	 	 
	 	 	 
	________________________	 	Title:

 

 

    	 	13	 

     

    

 

EXHIBIT B

 

CONSENT OF SPOUSE

 

I, ____________________, spouse
of __________________, acknowledge that I have read the Voting Agreement, dated as of_____________, to which this Consent is attached
as 0 (the “Agreement”), and that I know the contents of the Agreement. I am aware that the Agreement contains provisions
regarding the voting and transfer of shares of capital stock of the Company that my spouse may own, including any interest I might have
therein.

 

I hereby agree that my interest,
if any, in any shares of capital stock of the Company subject to the Agreement shall be irrevocably bound by the Agreement and further
understand and agree that any community property interest I may have in such shares of capital stock of the Company shall be similarly
bound by the Agreement.

 

I am aware that the legal,
financial and related matters contained in the Agreement are complex and that I am free to seek independent professional guidance or counsel
with respect to this Consent. I have either sought such guidance or counsel or determined after reviewing the Agreement carefully that
I will waive such right.

 

 

 

 

 

_______________________________

________________________

 

Dated: ________________

 

 

 

    	 	14Exhibit 10.10

 

LAST UPDATED -- 9/14/18

 

THE OFFER AND SALE OF THIS SECURITY INSTRUMENT
HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE
SECURITIES LAWS OF CERTAIN STATES. THIS SECURITY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS
PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM.

 

SIMPLE AGREEMENT FOR FUTURE
TOKENS

 

	Purchase Amount: $[                        ]	Effective Date: [                           ], 2018

 

FOR VALUE RECEIVED, Athena Bitcoin Inc.,
a Delaware corporation (together with any of its successors or assignees, the “Company”), hereby issues to the
undersigned purchaser (together with its permitted registered assigns, the “Purchaser”), the right (the “Right”)
to certain cryptographic tokens that represent an interest in the capital stock of the Company (each, a “Token”)
and/or shares of the Company’s capital stock (“Equity Securities”) equal in value to the “Purchase
Amount” set forth above, or such other amount as shall then equal the outstanding purchase
amount hereunder, subject to the terms set forth below.

 

1.                 
Events

 

(a)               
Qualified Financing.

 

(i)                    
In the event the Company consummates a Qualified Financing on or before the expiration or termination of this instrument, the Company
will automatically issue to the Purchaser a number of Tokens equal to the quotient obtained by dividing (A) the Outstanding Amount
by (B) the Discount Price.

 

(ii)                  
In connection with and prior to the issuance of Tokens by the Company to the Purchaser pursuant to this Section 1(a), the
Purchaser will (a) execute and deliver to the Company any and all other transaction documents related to this instrument, including but
not limited to verification of accredited investor status under the applicable securities laws; and (b) provide to the Company a public
cryptographic key (generated using the cryptographic algorithm specified by Company) to which the Company will allocate the Tokens issued
pursuant to this Section 1(a) (the “Network Address”). The Purchaser also shall surrender this instrument,
duly endorsed (or a notice to the effect that the original Agreement has been lost, stolen or destroyed and an agreement acceptable to
the Company whereby the Purchaser agrees to indemnify the Company from any loss incurred by it in connection with this instrument) at
the office of the Company at the closing of the Qualified Financing for cancellation; provided, however, that upon satisfaction
of the conditions set forth in this Section 1(a), this instrument shall be deemed converted and of no further force and effect,
whether or not it is delivered for cancellation as set forth in this sentence.

 

(b)              
Corporate Transaction.

 

(i)                    
If, prior to the consummation of a Qualified Financing and on or prior to the expiration or termination of this instrument, the
Company consummates a Corporate Transaction, then immediately prior to the consummation of such Corporate Transaction, all or a portion
of the Outstanding Amount may be converted (the “Converted Amount”), at the option of the Purchaser, into that
number of fully paid and non-assessable Equity Securities determined by dividing (A) the Outstanding Amount by (B) the Conversion
Price.

 

(ii)                  
In connection with and prior to the issuance of Equity Securities by the Company to the Purchaser pursuant to Section 1(b),
the Purchaser will execute and deliver to the Company any and all other transaction documents related to this instrument, including but
not limited to verification of accredited investor status under the applicable securities laws, execution of a definitive purchase agreement
and investor rights agreement. Before the Purchaser shall be entitled to convert this instrument into Equity Securities pursuant to this
Section 1(b), the Purchaser shall surrender this instrument, duly endorsed (or a notice to the effect that the original Agreement
has been lost, stolen or destroyed and an agreement acceptable to the Company whereby the Purchaser agrees to indemnify the Company from
any loss incurred by it in connection with this instrument), at the office of the Company and shall give written notice to the Company
at its principal corporate office of the Purchaser’s election to convert the same pursuant to Section 1(b), and shall state
therein the amount of the Outstanding Amount to be converted and the name or names in which the certificate or certificates for the Equity
Securities are to be issued. The Company shall, as soon as practicable thereafter (but in any case within five (5) business days after
the closing of the Corporate Transaction) and to the extent applicable, issue and deliver to the Purchaser a certificate or certificates
for the number of Equity Securities to which the Purchaser shall be entitled upon conversion (bearing such legends as are required by
the applicable equity purchase agreement, and applicable state and federal securities laws in the opinion of counsel to the Company).

 

 

    	 	1	 

     

    

 

(iii)                
If the Purchaser does not elect to convert all of the Outstanding Amount into Equity Securities, the Company will pay to the Purchaser
an amount in U.S. Dollars equal to the Outstanding Amount less the Converted Amount.

 

(c)               
Dissolution Event.

 

(i)                    
If there is a Dissolution Event before this instrument expires or terminates, the Company will pay an amount equal to the Outstanding
Amount, due and payable to the Purchaser immediately prior to, or concurrent with, the consummation of the Dissolution Event, subject
to any rights and preferences of the holders of the Company’s capital stock, as set forth in the Company’s Certificate of
Incorporation, as it may be amended from time to time. If immediately prior to the consummation of the Dissolution Event, the assets of
the Company that remain legally available for distribution to the Purchaser and all holders of all other SAFTs (the “Dissolving
Purchasers”), as determined in good faith by the Company’s board of directors, are insufficient to permit the payment
to the Dissolving Purchasers of their respective Outstanding Amounts, then the remaining assets of the Company legally available for distribution
to the Dissolving Purchasers will be distributed with equal priority and pro rata among the Dissolving Purchasers in proportion to their
respective Outstanding Amounts that they would otherwise be

entitled to receive pursuant to this Section 1(c). Any such
distributed amounts shall be in U.S. Dollars.

 

(ii)                  
The Purchaser acknowledges and agrees that the payment of all or any portion of the Outstanding Amount of this instrument shall
rank equally without preference or priority of any kind over the other SAFTs and shall be pari passu in right of payment and in
all other respects to the other SAFTs. In the event the Purchaser receives payments in excess of its pro rata share of the Company’s
payments to the other holders of SAFTs, then the Purchaser shall hold in trust all such excess payments for the benefit of the holders
of the other SAFTs and shall pay such amounts held in trust to such other holders upon demand by such holders.

 

(d)                  
Termination. This instrument will expire and terminate upon the earlier of (i) the issuance of Tokens to the Purchaser
pursuant to Section 1(a); (ii) the issuance of Equity Securities in value equal to the full Outstanding Amount pursuant to Section
1(b); (iii) the payment, or setting aside for payment, of amounts due the Purchaser pursuant to Section 1(c); (iv) the failure
to obtain net proceeds of more than $15,000,000 from the sale of all rights pursuant to the SAFTs on or prior to September 30, 2019 (the
“Deadline Date”), and (v) the Deadline Date, if a Qualified Financing has not occurred as of such date; provided,
that the Company shall have the right to extend the Deadline Date by sixty (60) days, in its sole and absolute discretion. In the event
of a termination pursuant to clauses (iv) or (v) of this Section 1(d) (a “Termination”), the Purchaser
will have the option to receive (A) an amount in U.S. Dollars equal to the sum of (1) the Outstanding Amount plus (2) the amount
accruing on the Outstanding Amount at a rate of 7.0% per annum from the date hereof until the effective date of the Termination, based
on a 365 day year and compounded on the anniversary of the date hereof (any such amount, a “Termination Payment”),
or (B) an amount of preferred equity in the Company equal in value to the Outstanding Amount pursuant to the terms and conditions of an
agreement approved by the Company and the holders of a majority of the aggregate Outstanding Amounts less the aggregate Termination Payment
Amounts, if any, to be made to all Purchasers in connection with such termination.

 

2.                 
Definitions

 

“Agreement”
means this Simple Agreement for Future Tokens (and all other Simple Agreements for Future Tokens issued in exchange, transfer or replacement
hereof).

 

“Corporate Transaction”
means (a) a sale, lease, transfer or other disposition, in a single transaction or a series of related transactions, by the Company or
any subsidiary of the Company of all or substantially all of the assets of the Company and its subsidiaries taken as a whole, except where
such sale, lease, transfer or other disposition is to the Company or one or more wholly owned subsidiaries of the Company, (b) a merger
of the Company with or into another entity (if after such merger, the holders of a majority of the Company’s voting securities immediately
prior to such merger do not hold a majority of the voting securities of the surviving entity) or (c) any transaction or a series of related
transactions (excluding a bona fide equity financing) in which a person or group of related persons acquires from holders of the Company’s
equity interests representing more than 50% of the outstanding voting power of the Company.

 

“Conversion Price”
means the price per share of common stock of the Company on a fully- diluted and as-converted basis implied by the valuation of the Company
as of the date of this

instrument, as determined in good faith by the
Company’s board of directors (or other equivalent governing body), based on the Company’s capitalization immediately prior
to the closing of the Corporate Transaction.

 

 

    	 	2	 

     

    

 

“Discount Price”
means the greater of (i) 50% of the initial price per Token sold by the Company on the date of the Qualified Financing, and (ii) the price
per each Token on a fully- diluted and as-converted basis implied by a $30,000,000 valuation of the Company, based on the Company’s
capitalization immediately prior to the closing of the Qualified Financing.

 

“Dissolution Event” means (i) a
voluntary termination of the operations of the Company, (ii) a general assignment for the benefit of the Company’s creditors
or (iii) any other liquidation, dissolution or winding up of the Company, whether voluntary or involuntary.

 

“Outstanding Amount”
means the Purchase Amount less the aggregate value on the date of issuance of any Tokens or Equity Securities that have been issued by
the Company in satisfaction of or pursuant to this instrument.

 

“Qualified Financing”
means the issuance (in one transaction or a series of related transactions) by the Company of Tokens following the date of this instrument
from which the Company receives aggregate gross cash proceeds of not less than Fifteen Million Dollars ($15,000,000), excluding the
aggregate amount of proceeds received in the same transaction or series of related transactions from the issuance of SAFTs, other agreements
for future Tokens, or promissory notes convertible into Equity Securities.

 

“SAFT”
means an agreement containing a future right to Tokens purchased by purchasers (collectively, together with the Purchaser, the “Purchasers”),
similar in form and content to this instrument.

 

3.                     
Company Representations. The Company hereby represents and warrants to the Purchaser that:

 

(a)                   
The Company is a corporation duly organized, validly existing and in good standing under the laws of Delaware, and has the power
and authority to own, lease and operate its properties and carry on its business as now conducted.

 

(b)                  
The execution, delivery and performance by the Company of this instrument is within the power of the Company and, other than with
respect to the actions to be taken when Tokens and/or Equity Securities are to be issued to the Purchaser, has been duly authorized by
all necessary actions on the part of the Company. This instrument constitutes a legal, valid and binding obligation of the Company, enforceable
against the Company in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating
to or affecting the enforcement of creditors’ rights generally and general principles of equity. To the knowledge of the Company,
it is not in violation of (i) its current articles of incorporation or bylaws, (ii) any material statute, rule or regulation applicable
to the Company, or (iii) any material indenture or contract to which the Company is a party or by which it is bound, where, in each case,
such violation or default, individually, or together with all such violations or defaults, could reasonably be expected to have a material
adverse effect on the Company.

 

(c)                   
To the knowledge of the Company, the performance and consummation of the transactions contemplated by this instrument do not and
will not: (i) violate any material judgment, statute, rule or regulation applicable to the Company; (ii) result in the acceleration of
any material indenture or contract to which the Company is a party or by which it is bound; or (iii) result in the creation or imposition
of any lien upon any property, asset or revenue of the Company or the suspension, forfeiture, or nonrenewal of any material permit, license
or authorization applicable to the Company, its business or operations.

 

(d)                  
No consents or approvals are required in connection with the performance of this instrument, other than: (i) the Company’s
corporate approvals; and (ii) any qualifications or filings under applicable securities laws.

 

4.                     
Purchaser Representations. The Purchaser hereby represents and warrants to the Company that:

 

(a)                   
Such Purchaser has full legal capacity, power and authority to execute and deliver this instrument and to perform its obligations
hereunder. This instrument constitutes valid and legally binding obligation of the Purchaser, enforceable in accordance with its terms,
except as may be limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors’
rights generally and general principles of equity.

 

(b)                  
Such Purchaser has been advised that this instrument is a security and that the offers and sales of this instrument have not been
registered under any country’s securities laws and, therefore, cannot be resold except in compliance with the applicable country’s
laws.

 

(c)                   
Such Purchaser is purchasing this instrument for its own account for investment, not as a nominee or agent, and not with a view
to, or for resale in connection with, the distribution thereof, and the Purchaser has no present intention of selling, granting any participation
in, or otherwise distributing the same.

 

 

    	 	3	 

     

    

 

(d)                  
Such Purchaser has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions
of the offering of the Right and to obtain additional information (to the extent the Company possessed such information or could acquire
it without unreasonable effort or expense) necessary to verify any information furnished to such Purchaser or to which such Purchaser
had access.

 

(e)                   
Such Purchaser understands that the purchase of the Right involves substantial risk. Such Purchaser has such knowledge and experience
in financial and business matters that such Purchaser is capable of evaluating the merits and risks of such investment, is able to incur
a complete loss of such investment without impairing the Purchaser’s financial condition and is able to bear the economic risk of
such investment for an indefinite period of time.

 

(f)                   
Such Purchaser agrees to be solely responsible for maintaining the secrecy and integrity of any and all private keys, wallets and
cryptographic seed associated with the Network Address, and such Purchaser understands that any loss, corruption, disclosure, or unauthorized
access with respect to such private keys, wallets or cryptographic seed could result in the permanent and irrevocable theft or loss of
Tokens allocated to such Network Address and for which Purchaser shall be solely responsible.

 

(g)                  
Such Purchaser is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities
Act.

 

(h)                  
Such Purchaser understands that the Tokens and Equity Securities are characterized as “restricted securities” under
the Securities Act and Rule 144 promulgated thereunder inasmuch as they are being acquired from the Company in a transaction not involving
a public offering, and that under the Securities Act and applicable regulations thereunder such Securities may be resold without registration
under the Securities Act only in certain limited circumstances. In this connection, such Purchaser is familiar with Rule 144, as presently
in effect, and understands the resale limitations imposed thereby and by the Securities Act. Such Purchaser understands that the Company
is under no obligation to register any of the securities sold hereunder. Such Purchaser understands that no public market now exists for
any of the securities and that it is uncertain whether a public market will ever exist for the securities.

 

5.                 
Procedures for Purchase of Rights and Valuation of Purchase Amount.

 

(a)                   
The Company will accept payment for the Right purchased under this instrument in U.S. Dollars, Bitcoin and/or Ether. Purchaser
shall make the required payment to the Company in consideration for Purchaser’s purchase of the Right pursuant to this instrument
through the procedures set forth on Exhibit A hereof.

 

(b)                  
For purposes of this instrument, the value of the Purchase Amount shall be deemed in U.S. Dollars whether the Purchaser pays in
U.S. Dollars, Bitcoin or Ether, valued at the Applicable Exchange Rate for U.S. Dollars. The term “Applicable Exchange Rate”
shall mean the buy price of U.S. Dollars on the Gemini digital currency exchange at 4:00 pm Eastern Time on business day following the
day that the Company notifies the Purchaser, in writing, that the Company has accepted Purchaser’s offer to purchase the Right under
this instrument.

 

6.                 
Miscellaneous.

 

(a)                   
This instrument sets forth the entire agreement and understanding of the parties relating to the subject matter herein and supersedes
all prior or contemporaneous disclosures, discussions, understandings and agreements, whether oral of written, between them. This instrument
is one of a series of similar instruments entered into by the Company from time to time. Any provision of this instrument may be amended,
waived or modified only upon the written consent of the Company and the holders of a majority, in the aggregate, of the Purchase Amounts
paid to the Company with respect to all SAFTs outstanding at the time of such amendment, waiver or modification; provided, however,
that no such amendment, waiver or consent shall, without the Purchaser’s prior written consent, reduce the Outstanding Amount under
this instrument.

 

(b)                  
Any notice required or permitted by this instrument will be deemed sufficient when sent by email to the relevant address listed
on the signature page, as may be subsequently modified by written notice received by the appropriate party, with confirmation of receipt.

 

(c)                   
The Purchaser is not entitled, as a holder of this instrument, to vote or receive dividends or be deemed the holder of capital
stock of the Company for any purpose, nor will anything contained herein be construed to confer on the Purchaser, as such, any of the
rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter

submitted to stockholders at any meeting thereof, or to give or withhold
consent to any corporate action or to receive notice of meetings, or to receive subscription rights or otherwise.

 

 

    	 	4	 

     

    

 

(d)                  
Neither this instrument nor the rights contained herein may be assigned, by operation of law or otherwise, by either party without
the prior written consent of the other; provided, however, that this instrument and/or the rights contained herein may be assigned
without the Company’s consent by the Purchaser to any other entity who directly or indirectly, controls, is controlled by or is
under common control with the Purchaser, including, without limitation, any general partner, managing member, officer or director of the
Purchaser, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members
of, or shares the same management company with, the Purchaser; and provided, further, that the Company may assign this instrument
in whole, without the consent of the Purchaser, in connection with a reincorporation to change the Company’s domicile or a reorganization
or restructuring of the Company. Subject to the restrictions on transfer described in this Section 6(d), the rights and obligations
of the Company and the Purchaser shall be binding upon and benefit the successors, assigns, heirs and administrators and transferees of
the parties.

 

(e)                   
In the event any one or more of the provisions of this instrument is for any reason held to be invalid, illegal or unenforceable,
in whole or in part or in any respect, or in the event that any one or more of the provisions of this instrument operate or would prospectively
operate to invalidate this instrument, then and in any such event, such provision(s) only will be deemed null and void and will not affect
any other provision of this instrument and the remaining provisions of this instrument will remain operative and in full force and effect
and will not be affected, prejudiced, or disturbed thereby.

 

(f)                   
All rights and obligations hereunder will be governed by the laws of Delaware, without regard to the conflicts of law provisions
of such jurisdiction. The parties hereto agree that the exclusive venue for disputes between them shall be resolved by the federal and
state courts located in Chicago, Illinois, and each of the parties hereto waives any objection it may have to the personal jurisdiction
of or venue in such courts.

 

(g)              
This instrument is a general unsecured obligation of the Company.

 

(h)                  
This instrument may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an
original, and such counterparts shall together constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic
mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission
method, and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

 

(i)                    
From time to time, the Company and the Purchaser shall execute and deliver to the other such additional documents and shall provide
such additional information as the Purchaser or Company may reasonably require to carry out the terms of this instrument and any agreements
executed in connection herewith.

 

(j)                    
All amounts expressed herein without reference to a currency will be deemed to be in U.S. dollars.

 

(k)                  
EACH OF THE PARTIES HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ALL RIGHT TO A TRIAL BY JURY IN ANY
ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS INSTRUMENT OR ANY TRANSACTION CONTEMPLATED BY THIS INSTRUMENT OR
DISPUTES RELATING THERETO.

 

(Signature page follows)

 

 

    	 	5	 

     

    

 

IN WITNESS WHEREOF, the undersigned have caused
this instrument to be duly executed and delivered.

 

ATHENA BITCOIN INC.

 

 

By: Eric Gravengaard

Chief Executive Officer

 

Address:

211 W. Wacker Drive Suite 900b

Chicago, Illinois 60606

 

Email: tokensale@athenabitcoin.com

 

PURCHASER:

 

 

By: _____________________________

 

Name: ___________________________

 

Address: _________________________

 

________________________________

 

________________________________

 

Email: ___________________________

 

Only if investing as an entity:

 

Title: ____________________________

 

Company: ________________________

 

Entity Type: _______________________

 

Domicile: _________________________

 

 

    	 	6	 

     

    

 

Exhibit A

 

 

[Wire Instructions, BTC and ETH Addresses to be generated upon completion
of this document by purchaser]

 

 

 

 

 

 

 

 

 

    	 	7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]